WO2012032540A1 - Process for preparation of fluorinated triazole compound - Google Patents

Process for preparation of fluorinated triazole compound Download PDF

Info

Publication number
WO2012032540A1
WO2012032540A1 PCT/IN2011/000607 IN2011000607W WO2012032540A1 WO 2012032540 A1 WO2012032540 A1 WO 2012032540A1 IN 2011000607 W IN2011000607 W IN 2011000607W WO 2012032540 A1 WO2012032540 A1 WO 2012032540A1
Authority
WO
WIPO (PCT)
Prior art keywords
formula
reaction
azide
compound
sodium
Prior art date
Application number
PCT/IN2011/000607
Other languages
French (fr)
Inventor
Mangesh Narayan Rajadhyaksha
Ranjeet Nair
V Ramesan P
Johnson K.
Aditi Milind Panandikar
Original Assignee
Indoco Remedies Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indoco Remedies Limited filed Critical Indoco Remedies Limited
Publication of WO2012032540A1 publication Critical patent/WO2012032540A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Definitions

  • the present invention relates to an improved process for the preparation of 1 -[(2,6- difluorophenyl)methyl]- 1H- 1 ,2,3-triazole-4-carboxamide of Formula I,
  • the compound l-[(2,6-difluorophenyl)methyl]-lH-l,2,3-triazole-4-carboxamide of Formula I having International non - proprietary name Rufinamide is an anticonvulsive drug.
  • the compound was first described in US 4789680, wherein 2,6-difluorobenzyl bromide of Formula IIB is reacted with sodium azide in presence of dimethyl sulfoxide to obtain 2,6-difluorobenzyl azide of Formula III.
  • the compound of Formula III is reacted with propiolic acid Formula IV in toluene at 70°C to get l-(2,6-Difluorobenzyl)-lH- l,2,3-triazole-4-carboxylic acid of Formula V.
  • the compound of Formula V is reacted with thionyl chloride and distilling out excess of thionyl chloride to get residual mass of 1 -(2,6-difluorobenzyl)- lH-l,2,3-triazole-4-carbonyl chloride of Formula VI.
  • the compound of formula VI is further taken in toluene and reacted with aqueous ammonia to isolate Rufinamide.
  • the present inventors have now come out with an improved process which involves "click chemistry" concept using catalyst during the reaction, ameliorates the drawbacks in prior art and avoids high temperature of reaction, handling of hazardous alkyl azide compounds, formation of regio isomer and impurities.
  • the object of the present invention is to prepare the compound l-[(2,6- difluorophenyl)methyl]-lH-l,2,3-triazole-4-carboxamide of Formula I with an improved, efficient process and reduced number of steps with good yield.
  • Another object of the present invention is regiocontrolled synthesis of the compound l-[(2,6-difluorophenyl)methyl]-lH-l,2,3-triazole-4-carboxamide of Formula I, substantially free from the regio isomer and the impurities.
  • Yet another object of the present invention is the preparation of intermediate compound of Formula XA
  • the present invention provides an improved process for the preparation of the compound l-[(2,6-difluorophenyl)methyl]-lH-l,2,3-triazole-4-carboxamide of Formula I;
  • R is -COORi, wherein R ⁇ is hydrogen, d-C4 linear or branched alkyl group, or -CN, or -CONH 2 or -CH 2 -OR 2 , where R 2 is hydrogen or hydroxyl protecting group, in presence of an azide, Cu(I) species and a catalyst.
  • R is -COORj , wherein Rj is hydrogen, C1-C4 linear or branched alkyl group or -CN or -CH 2 -OR 2j wherein R 2 is hydrogen or hydroxyl protecting group; and converting the intermediate compound of Formula X to Rufinamide of Formula I.
  • the present invention discloses preparation of [l-(2,6-difluorobenzyl)- lH-l,2,3-triazol-4-yl]methanol, compound of Formula XA which comprises regioselective cycloaddition of 2,6-difluorobenzyl bromide of Formula IIA with propargyl alcohol of Formula IXB, in presence of an azide, Cu(I) species, phase transfer catalyst, potassium iodide and solvent at a moderate temperature condition.
  • the compound of Formula XA is further subjected to oxidation reaction in presence of a buffer, a catalyst, an oxidizing agent and solvent to get the compound 1- (2,6-difluorobenzyl)-lH-l,2,3-triazole-4-carboxylic acid of Formula XB which is then further converted to Rufinamide as per the prior art process.
  • the present invention discloses the novel compound [l-(2,6-difluorobenzyl)- lH-l,2,3-triazol-4-yl]methanol, of Formula XA;
  • the present invention describes the process in detail for the preparation of the compound l-[(2,6-difluorophenyl)methyl]-lH-l,2,3-triazole-4-carboxamide of Formula I, involving "click chemistry" by carrying out regiocontrolled cycloaddition reaction of the compound of Formula II and Formula IX in presence of an azide, Cu(I) species, a catalyst, and solvent.
  • the compound 2,6-difluorobenzyl halide of Formula II wherein X is selected from chloride, bromide or iodide undergoes regioselective cycloaddition reaction with the compound of Formula IX, where R is COOR], wherein R] is hydrogen, C 1 -C4 linear or branched alkyl group, or -CN or CH 2 -OR 2j wherein R 2 is hydrogen or hydroxyl protecting group, in presence of an azide, Cu(I) species, a catalyst, a reducing agent and solvent at a moderate temperature condition.
  • R is -COOR ⁇ wherein R ⁇ is hydrogen, C1-C4 linear or branched alkyl group, or -CN, or- CONH 2 or -CH 2 -OR 2j where R 2 is hydrogen or hydroxyl protecting group.
  • the azide compound used in regioselective cycloaddition reaction is selected from a metal azide or an alkyl silyl azide.
  • the metal azide used is selected from sodium azide or potassium azide and the alkyl silyl azide is trimethylsilyl azide.
  • the preferred azide compound used for the regioselective cycloaddition reaction is metal azide selected from sodium azide or potassium azide, wherein the most preferred metal azide used is sodium azide.
  • the Cu(I) species used for the reaction is generated insitu by reaction of Cu(II) species with reducing agent selected from sodium bisulfite, sodium metabisulfite, ascorbic acid or its salts preferably sodium ascorbate.
  • the Cu (II) species used for the reaction are selected from CuS0 4 .5H 2 0, CuCl 2 , Cul 2 , Cu/AlO (OH) or Cu (II) salts supported on carbon, silica and alumina.
  • Cu (I) species can be obtained directly from Cul, CuCl or any other cuprous salt.
  • the preferred Cu (II) species used in the reaction is CuS0 4 .5H 2 0 with sodium ascorbate.
  • the catalyst used in the regioselective cycloaddition reaction is phase transfer catalyst selected from tetrabutyl ammonium bromide, tetrabutyl ammonium chloride, benzyl triethyl ammonium chloride and benzyl triethyl ammonium bromide.
  • the preferred phase transfer catalyst used is tetrabutyl ammonium bromide [TBAB].
  • the solvent used for the regioselective cycloaddition reaction is selected from polar solvents such as water, Cj-C 4 linear or branched alcohol, acetone, ethyl acetate, methyl ethyl ketone and methyl isobutyl ketone, acetonitrile, dimethyl sulfoxide, N,N- dimethylformamide either single or mixture thereof.
  • polar solvents such as water, Cj-C 4 linear or branched alcohol, acetone, ethyl acetate, methyl ethyl ketone and methyl isobutyl ketone, acetonitrile, dimethyl sulfoxide, N,N- dimethylformamide either single or mixture thereof.
  • the preferred polar solvents used for the regioselective cycloaddition reaction is water and Ci-C 4 linear or branched alcohol either single or mixture thereof, wherein CrC 4 linear or branched alcohol are methanol, ethanol, w-propanol, w-butanol, isopropanol, and tert-butanol.
  • the most preferred solvent used for the regioselective cycloaddition reaction is mixture of water and tert-butanol.
  • the ratio of solvent mixture of water and tert-butanol used for the reaction is 1: 15 or 15: 1 v/v.
  • the regioselective cycloaddition reaction is carried out at moderate temperature in the range of 10°C to 50°C.
  • the preferred temperature range for the reaction is 15°C to 35°C, wherein the most preferred temperature range used for the reaction is 25°C to 30°C.
  • the regioselective cycloaddition reaction is carried out in presence of potassium iodide used as an initiator.
  • the general reaction sequence can be represented as shown in the scheme 4 below;
  • the compound 2,6-difluorobenzyl bromide of Formula IIA undergoes regioselective cycloaddition reaction with the compound methyl propiolate of Formula IXA, in presence of an azide, Cu(I) species, phase transfer catalyst, potassium iodide and solvent at a moderate temperature condition to give the compound l-[(2,6-difluorophenyl)methyl]-lH-l,2,3-triazole-4-carboxamide of Formula I in a two step process.
  • the azide compound used in regioselective cycloaddition reaction is sodium azide.
  • the Cu(I) species used for the reaction is generated insitu by reaction of Cu(II) species with reducing agent selected from sodium bisulfite, sodium metabisulfite, ascorbic acid or its salts preferably sodium ascorbate.
  • the Cu(II) species used for the reaction are selected from CuS0 4 .5H 2 0, CuCl 2 , Cul 2 , Cu A10(OH) or Cu(II) salts supported on carbon, silica or alumina.
  • Cu (I) species can be obtained directly from Cul, CuCl or any other cuprous salt.
  • the preferred Cu (II) species used in the reaction is CuS0 4 .5H 2 0 with sodium ascorbate.
  • the catalyst used in the regioselective cycloaddition reaction is phase transfer catalyst selected from tetrabutyl ammonium bromide, tetrabutyl ammonium chloride, benzyl triethyl ammonium chloride and benzyl triethyl ammonium bromide.
  • the preferred phase transfer catalyst used is tetrabutyl ammonium bromide.
  • the solvent used for the regioselective cycloaddition reaction is selected from polar solvents such as water, C]-C 4 linear or branched alcohol, acetone, ethyl acetate, methyl ethyl ketone and methyl isobutyl ketone, acetonitrile, dimethyl sulfoxide, N,N- dimethylformamide either single or mixture thereof.
  • the preferred solvent used for the reaction is selected from water and Q-C4 linear or branched alcohol, wherein C1-C4 linear or branched alcohol are selected from methanol, ethanol, n-propanol, M-butanol, isopropanol, and tert-butanol.
  • the most preferred solvent used for the regioselective cycloaddition reaction is mixture of water and ter/-butanol.
  • the ratio of solvent mixture of water and fert-butanol used for the reaction is 1: 15 or 15: 1 v/v, wherein the preferred ratio of water and tert-butanol is in the ratio of 1 : 9 v/v.
  • the regioselective cycloaddition reaction is carried out at moderate temperature in the range of 10°C to 50°C.
  • the preferred temperature range for the reaction is 15°C to 35°C, wherein the most preferred temperature range used for the reaction is 25°C to 30°C.
  • the reaction is maintained under stirring for 4 to 6 hours.
  • the solid product separated may be filtered and taken in water or the reaction is continued as such without filtration.
  • Ammonia in the form of gaseous ammonia or aqueous ammonia is added to the reaction mass for amide formation.
  • the reaction is carried out at a temperature in the range of 50-80°C.
  • the time for the completion of the amidation reaction is 4-12 hours.
  • the compound l-[(2,6-difluorophenyl)methyl]-lH-l,2,3-triazole-4-carboxamide (Rufinamide) of Formula I is isolated by filtration at 25-30°C and dried till constant weight.
  • 2,6-difluorobenzyl bromide of Formula IIA undergoes regioselective cycloaddition reaction with propargyl alcohol of Formula IXB, in presence of an azide, Cu(I) species, phase transfer catalyst, potassium iodide and solvent at a moderate temperature condition to get [l-(2,6-difluorobenzyl)-lH- l,2,3-triazol-4-yl]methanol of Formula XA.
  • the azide compound used in regioselective cycloaddition reaction is sodium azide.
  • the Cu(I) species used for the reaction is generated insitu by reaction of Cu(II) species with reducing agent selected from sodium bisulfite, sodium metabisulfite, ascorbic acid or its salts preferably sodium ascorbate.
  • the Cu(II) species used for the reaction are selected from CuS0 4 .5H 2 0, CuCl 2 , Cul 2 , Cu/A10(OH) or Cu(II) salts supported on carbon, silica or alumina.
  • Cu(I) species can be obtained directly from Cul, CuCl or any other cuprous salt.
  • the preferred Cu(II) species used in the reaction is CuS0 4 .5H 2 0 with sodium ascorbate.
  • the catalyst used in the regioselective cycloaddition reaction is phase transfer catalyst selected from tetrabutyl ammonium bromide, tetrabutyl ammonium chloride, benzyl triethyl ammonium chloride and benzyl triethyl ammonium bromide.
  • the preferred phase transfer catalyst used is tetrabutyl ammonium bromide.
  • the solvent used for the regioselective cycloaddition reaction is selected from polar solvents such as water, C C 4 linear or branched alcohol, acetone, ethyl acetate, methyl ethyl ketone and methyl isobutyl ketone, acetonitrile, dimethylsulfoxide, N,N- dimethylformamide either single or mixture thereof.
  • the preferred solvent used for the reaction is selected from water and C1-C4 linear or branched alcohol, wherein Ci-C 4 linear or branched alcohol are selected from methanol, ethanol, w-propanol, n-butanol, isopropanol, and tert-butanol.
  • the most preferred solvent used for the regioselective cycloaddition reaction is mixture of water and tert-butanol.
  • the ratio of solvent mixture of water and tert-butanol used for the reaction is 1 : 15 or 15: 1 v/v, wherein the preferred ratio of water and tert-butanol is in the ratio of 1 : 9 v/v.
  • the regioselective cycloaddition reaction is carried out at moderate temperature in the range of 10°C to 50°C, wherein the preferred temperature for the reaction is 15°C to 35°C and the most preferred temperature used for the reaction is 25°C to 30°C.
  • reaction temperature is maintained at 25°C to 30°C under stirring for 4 to 6 hours.
  • ammonia in the form of gaseous ammonia or aqueous ammonia is added to the reaction mass and stirred for 2 to 4 hours at 0°C to 10°C. Filtered the solid compound of [l-(2,6-difluorobenzyl)-lH-l,2,3-triazol-4- yl]methanol of Formula XA.
  • the compound [l-(2,6-difluorobenzyl)- lH-l,2,3-triazol-4-yl]methanol of Formula XA is subjected to oxidation reaction in presence of a buffer, a catalyst, an oxidizing agent and solvent to get the compound 1- (2,6-difluorobenzyl)-lH-l,2,3-triazole-4-carboxylic acid of Formula XB.
  • the buffer used for the oxidation reaction is selected from sodium dihydrogen phosphate, disodium hydrogen phosphate, and ammonium acetate, either single or mixture thereof.
  • the preferred buffer used for the reaction is mixture of sodium dihydrogen phosphate and disodium hydrogen phosphate.
  • the molar ratio of the mixture of sodium dihydrogen phosphate and disodium hydrogen phosphate used is 0.5: 1.0 to 1.0: 0.5.
  • the preferred molar ratio of sodium dihydrogen phosphate and disodium hydrogen phosphate used is 1.0: 0.9.
  • the catalyst used for the oxidation reaction is (2,2,6,6-Tetramethylpiperidin-l-yl)oxyl [TEMPO].
  • the oxidizing agent used is mixture of sodium chlorite and sodium hypochlorite in the molar ratio of 2.5: 0.5.
  • the solvent used for the oxidation reaction is selected from acetonitrile, N,N- dimethylformamide, ⁇ , ⁇ -dimethylacetamide, dimethylsulfoxide and tetrahydrofuran.
  • the preferred solvent used for the oxidation reaction is selected from acetonitrile and tetrahydrofuran, wherein the most preferred solvent used for the oxidation reaction is tetrahydrofuran.
  • the oxidation reaction is carried out at temperature in the range of 20°C to 40°C, wherein the preferred temperature of the oxidation reaction is between 35°C to 40°C.
  • the time for completion of oxidation reaction is 4 to 6 hours.
  • the pH of the reaction mass is adjusted to 8 - 9 using aqueous sodium hydroxide solution.
  • the reaction solution is extracted with toluene or diethyl ether and separated the organic layer.
  • the pH of the aqueous layer is adjusted to 1 - 2 using dilute aqueous hydrochloric acid.
  • the reaction mass is cooled to 0°C to 5°C and maintained 2 - 3 hours under stirring.
  • reaction sequence of the present invention can be represented as in scheme 5;
  • the corresponding compound of Formula X can be hydrolysed, with aqueous sodium hydroxide at temperature of 90°C to 100°C to isolate the final compound Rufinamide of Formula I.
  • the compound of Formula IX where R is -CH 2 OR 2 , wherein R 2 is hydroxyl protecting group selected from acetyl, benzyl or benzoyl groups results in an intermediate triazole compound which is first deprotected by suitable deprotecting method to get the compound of Formula XA. This is followed by a process for the preparation of Rufinamide of Formula I as per the reaction scheme 5 described above.
  • the present invention discloses the novel compound [l-(2,6- difluorobenzyl)-lH-l,2,3-triazol-4-yl]methanol, of Formula XA;
  • the present invention demonstrates an improved, efficient process for the preparation of Rufinamide which is substantially free from the regio isomer impurities, with reduced number of steps and giving good yield.

Abstract

The present invention discloses a process for the preparation of 1-[(2,6-difluorophenyl)methyl]-1H-1,2,3-triazole-4-carboxamide of Formula (I), comprising regioselective cycloaddition of 2,6-difluorobenzyl halide of Formula (II), wherein X is chloride, bromide or iodide; with a compound of Formula (IX); in which R is -COOR1, wherein R1 is hydrogen, C1-C4 linear or branched alkyl group, or-CN, or-CONH2 or -CH2OR2j wherein R2 is hydrogen or hydroxyl protecting group; in presence of an azide, Cu(I) species and a catalyst.

Description

"PROCESS FOR PREPARATION OF FLUORINATED TRIAZOLE
COMPOUND"
RELATED APPLICATION:
This invention claims priority from its Indian provisional application No. 2477/MUM/2010 filed on 06.09.2010.
FIELD OF INVENTION:
The present invention relates to an improved process for the preparation of 1 -[(2,6- difluorophenyl)methyl]- 1H- 1 ,2,3-triazole-4-carboxamide of Formula I,
Figure imgf000003_0001
Formula I
BACKGROUND AND PRIOR ART:
The compound l-[(2,6-difluorophenyl)methyl]-lH-l,2,3-triazole-4-carboxamide of Formula I having International non - proprietary name Rufinamide is an anticonvulsive drug. The compound was first described in US 4789680, wherein 2,6-difluorobenzyl bromide of Formula IIB is reacted with sodium azide in presence of dimethyl sulfoxide to obtain 2,6-difluorobenzyl azide of Formula III. The compound of Formula III is reacted with propiolic acid Formula IV in toluene at 70°C to get l-(2,6-Difluorobenzyl)-lH- l,2,3-triazole-4-carboxylic acid of Formula V. The compound of Formula V is reacted with thionyl chloride and distilling out excess of thionyl chloride to get residual mass of 1 -(2,6-difluorobenzyl)- lH-l,2,3-triazole-4-carbonyl chloride of Formula VI. The compound of formula VI is further taken in toluene and reacted with aqueous ammonia to isolate Rufinamide.
Another process is also disclosed in US 4789680, wherein the compound 1 -(2,6- Difluorobenzyl)-lH-l,2,3-triazole-4-carboxylic acid of Formula V is reacted with methanol in presence of sulfuric acid to get methyl l -(2,6-Difluorobenzyl)-lH- 1,2,3- triazole-4-carboxylate of Formula VII, which on reaction with methanolic ammonia results in the compound Rufinamide of Formula I. The reaction sequence can be represented as in scheme - 1 below;
Figure imgf000004_0001
Formula ΠΒ Formula III
Figure imgf000004_0002
Formula V
Formula VII
Figure imgf000004_0003
Formula I Formula VI
Scheme 1
Another process disclosed in the patent application WO9802423; wherein 2,6- difluorobenzyl azide of Formula III is reacted with 2-chloroacrylonitrile of Formula VIII in water for 24 hours. The excess of 2-chloroacrylonitrile is distilled out up to 113°C and hydrolysed the intermediate cyano compound with sodium hydroxide solution in presence of toluene to obtain the compound of Formula I. The reaction sequence is as given in scheme 2 below;
Figure imgf000005_0001
Formula I
Scheme 2
Another process disclosed in patent application WO2010043849; wherein the compound 2,6-difluorobenzyl bromide of Formula IIB is reacted with sodium azide in water at 70- 75°C for about 30 hours to get 2,6-difluorobenzyl azide of Formula III. To the cooled reaction mass methyl propiolate of Formula IX is added and maintained at 60-65°C for 4- 5 hours to get intermediate compound methyl l-(2,6-difluorobenzyl)-lH-l,2,3-triazole-4- carboxylic acid of Formula VII. To the reaction mass ammonia solution is charged to get Rufinamide of Formula I. The reaction sequence is as per scheme 3 below;
Figure imgf000005_0002
Formula IIB Formula III Formula VII
Figure imgf000005_0003
Formula I
Scheme 3
In the above prior arts, the yield of Rufinamide obtained is low as the reaction requires heating which results in poor regioselectivity at the time of cyclisation giving a mixture of 1,4 and 1,5 disubstituted isomers of l-[(2,6-difluorophenyl)methyl]-lH-l,2,3-triazole-4- carboxamide of Formula I and l-[(2,6-difluorophenyl)methyl]-lH-l,2,3-triazole-5- carboxamide of Formula IA.
Figure imgf000006_0001
Formula I
Formula IA
Other drawbacks in the above prior arts are:
i. involves multiple process steps to get Rufinamide;
ii. heating of the reactants resulting in decomposition of the reaction mass resulting in the impurities;
iii. use and handling of hazardous alkyl azide compounds.
It is evident from the prior art that there remains a need for an improved process to prepare the compound l-[(2,6-difluorophenyl)methyl]-lH-l,2,3-triazole-4-carboxamide of Formula I which has good regioselectivity of the reaction, avoids multiple process steps, avoids handling of alkyl azide compounds and formation of impurities during the reaction, thus resulting in improved yield of the compound of Formula I.
The present inventors have now come out with an improved process which involves "click chemistry" concept using catalyst during the reaction, ameliorates the drawbacks in prior art and avoids high temperature of reaction, handling of hazardous alkyl azide compounds, formation of regio isomer and impurities.
OBJECT OF THE INVENTION:
The object of the present invention is to prepare the compound l-[(2,6- difluorophenyl)methyl]-lH-l,2,3-triazole-4-carboxamide of Formula I with an improved, efficient process and reduced number of steps with good yield.
Another object of the present invention is regiocontrolled synthesis of the compound l-[(2,6-difluorophenyl)methyl]-lH-l,2,3-triazole-4-carboxamide of Formula I, substantially free from the regio isomer and the impurities. Yet another object of the present invention is the preparation of intermediate compound of Formula XA
Figure imgf000007_0001
Formula XA
SUMMARY OF THE INVENTION:
Accordingly, the present invention provides an improved process for the preparation of the compound l-[(2,6-difluorophenyl)methyl]-lH-l,2,3-triazole-4-carboxamide of Formula I;
Figure imgf000007_0002
Formula I
comprising regioselective cycloaddition of 2,6-difluorobenzyl halide of Formula II, wherein X is chloride, bromide or iodide;
Figure imgf000007_0003
Formula II
with a compound of Formula IX,
Figure imgf000007_0004
Formula IX
where R is -COORi, wherein R\ is hydrogen, d-C4 linear or branched alkyl group, or -CN, or -CONH2 or -CH2-OR2, where R2 is hydrogen or hydroxyl protecting group, in presence of an azide, Cu(I) species and a catalyst.
Accordingly the compound 2,6-difluorobenzyl halide of Formula II, wherein X is chloride, bromide or iodide is reacted with the compound of Formula IX in presence of an azide, Cu(I) species and catalyst, undergoing cycloaddition reaction to give an intermediate compound of Formula X;
Figure imgf000008_0001
Formula X
where R is -COORj, wherein Rj is hydrogen, C1-C4 linear or branched alkyl group or -CN or -CH2-OR2j wherein R2 is hydrogen or hydroxyl protecting group; and converting the intermediate compound of Formula X to Rufinamide of Formula I.
In another aspect, the present invention discloses preparation of [l-(2,6-difluorobenzyl)- lH-l,2,3-triazol-4-yl]methanol, compound of Formula XA which comprises regioselective cycloaddition of 2,6-difluorobenzyl bromide of Formula IIA with propargyl alcohol of Formula IXB, in presence of an azide, Cu(I) species, phase transfer catalyst, potassium iodide and solvent at a moderate temperature condition.
In another aspect, the compound of Formula XA is further subjected to oxidation reaction in presence of a buffer, a catalyst, an oxidizing agent and solvent to get the compound 1- (2,6-difluorobenzyl)-lH-l,2,3-triazole-4-carboxylic acid of Formula XB which is then further converted to Rufinamide as per the prior art process.
In an aspect, the present invention discloses the novel compound [l-(2,6-difluorobenzyl)- lH-l,2,3-triazol-4-yl]methanol, of Formula XA;
Figure imgf000008_0002
Formula XA
The invention will now be described in detail in connection with certain preferred and optional embodiments, so that various aspects thereof may be more fully understood and appreciated. DETAILED DESCRIPTION OF THE INVENTION:
The present invention describes the process in detail for the preparation of the compound l-[(2,6-difluorophenyl)methyl]-lH-l,2,3-triazole-4-carboxamide of Formula I, involving "click chemistry" by carrying out regiocontrolled cycloaddition reaction of the compound of Formula II and Formula IX in presence of an azide, Cu(I) species, a catalyst, and solvent.
In one embodiment of the present invention, the compound 2,6-difluorobenzyl halide of Formula II, wherein X is selected from chloride, bromide or iodide undergoes regioselective cycloaddition reaction with the compound of Formula IX, where R is COOR], wherein R] is hydrogen, C1-C4 linear or branched alkyl group, or -CN or CH2-OR2j wherein R2 is hydrogen or hydroxyl protecting group, in presence of an azide, Cu(I) species, a catalyst, a reducing agent and solvent at a moderate temperature condition.
Accordingly, the present process for the preparation of l-[(2,6-difluorophenyl)methyl]- lH-l,2,3-triazole-4-carboxamide, compound of Formula I;
Figure imgf000009_0001
Formula I
comprises the steps of regioselective cycloaddition of 2,6-difluorobenzyl halide of Formula II, wherein X is chloride, bromide or iodide;
Figure imgf000009_0002
Formula II
with a compound of Formula IX, in presence of an azide, Cu(I) species, catalyst and solvent at a moderate temperature condition,
Figure imgf000009_0003
Formula IX where R is -COOR^ wherein R\ is hydrogen, C1-C4 linear or branched alkyl group, or -CN, or- CONH2 or -CH2-OR2j where R2 is hydrogen or hydroxyl protecting group.
The azide compound used in regioselective cycloaddition reaction is selected from a metal azide or an alkyl silyl azide. The metal azide used is selected from sodium azide or potassium azide and the alkyl silyl azide is trimethylsilyl azide. The preferred azide compound used for the regioselective cycloaddition reaction is metal azide selected from sodium azide or potassium azide, wherein the most preferred metal azide used is sodium azide.
The Cu(I) species used for the reaction is generated insitu by reaction of Cu(II) species with reducing agent selected from sodium bisulfite, sodium metabisulfite, ascorbic acid or its salts preferably sodium ascorbate. The Cu (II) species used for the reaction are selected from CuS04.5H20, CuCl2, Cul2, Cu/AlO (OH) or Cu (II) salts supported on carbon, silica and alumina. Alternatively, Cu (I) species can be obtained directly from Cul, CuCl or any other cuprous salt. The preferred Cu (II) species used in the reaction is CuS04.5H20 with sodium ascorbate.
The catalyst used in the regioselective cycloaddition reaction is phase transfer catalyst selected from tetrabutyl ammonium bromide, tetrabutyl ammonium chloride, benzyl triethyl ammonium chloride and benzyl triethyl ammonium bromide. The preferred phase transfer catalyst used is tetrabutyl ammonium bromide [TBAB].
The solvent used for the regioselective cycloaddition reaction is selected from polar solvents such as water, Cj-C4 linear or branched alcohol, acetone, ethyl acetate, methyl ethyl ketone and methyl isobutyl ketone, acetonitrile, dimethyl sulfoxide, N,N- dimethylformamide either single or mixture thereof. The preferred polar solvents used for the regioselective cycloaddition reaction is water and Ci-C4 linear or branched alcohol either single or mixture thereof, wherein CrC4 linear or branched alcohol are methanol, ethanol, w-propanol, w-butanol, isopropanol, and tert-butanol. The most preferred solvent used for the regioselective cycloaddition reaction is mixture of water and tert-butanol. The ratio of solvent mixture of water and tert-butanol used for the reaction is 1: 15 or 15: 1 v/v. The regioselective cycloaddition reaction is carried out at moderate temperature in the range of 10°C to 50°C. The preferred temperature range for the reaction is 15°C to 35°C, wherein the most preferred temperature range used for the reaction is 25°C to 30°C.
The regioselective cycloaddition reaction is carried out in presence of potassium iodide used as an initiator. The general reaction sequence can be represented as shown in the scheme 4 below;
Figure imgf000011_0001
Formula X
Scheme 4
Wherein "X" and "R" are as defined above.
In another embodiment of the present invention, the compound 2,6-difluorobenzyl bromide of Formula IIA, undergoes regioselective cycloaddition reaction with the compound methyl propiolate of Formula IXA, in presence of an azide, Cu(I) species, phase transfer catalyst, potassium iodide and solvent at a moderate temperature condition to give the compound l-[(2,6-difluorophenyl)methyl]-lH-l,2,3-triazole-4-carboxamide of Formula I in a two step process.
The azide compound used in regioselective cycloaddition reaction is sodium azide. The Cu(I) species used for the reaction is generated insitu by reaction of Cu(II) species with reducing agent selected from sodium bisulfite, sodium metabisulfite, ascorbic acid or its salts preferably sodium ascorbate. The Cu(II) species used for the reaction are selected from CuS04.5H20, CuCl2, Cul2, Cu A10(OH) or Cu(II) salts supported on carbon, silica or alumina. Alternatively Cu (I) species can be obtained directly from Cul, CuCl or any other cuprous salt. The preferred Cu (II) species used in the reaction is CuS04.5H20 with sodium ascorbate.
The catalyst used in the regioselective cycloaddition reaction is phase transfer catalyst selected from tetrabutyl ammonium bromide, tetrabutyl ammonium chloride, benzyl triethyl ammonium chloride and benzyl triethyl ammonium bromide. The preferred phase transfer catalyst used is tetrabutyl ammonium bromide.
The solvent used for the regioselective cycloaddition reaction is selected from polar solvents such as water, C]-C4 linear or branched alcohol, acetone, ethyl acetate, methyl ethyl ketone and methyl isobutyl ketone, acetonitrile, dimethyl sulfoxide, N,N- dimethylformamide either single or mixture thereof. The preferred solvent used for the reaction is selected from water and Q-C4 linear or branched alcohol, wherein C1-C4 linear or branched alcohol are selected from methanol, ethanol, n-propanol, M-butanol, isopropanol, and tert-butanol. The most preferred solvent used for the regioselective cycloaddition reaction is mixture of water and ter/-butanol. The ratio of solvent mixture of water and fert-butanol used for the reaction is 1: 15 or 15: 1 v/v, wherein the preferred ratio of water and tert-butanol is in the ratio of 1 : 9 v/v.
The regioselective cycloaddition reaction is carried out at moderate temperature in the range of 10°C to 50°C. The preferred temperature range for the reaction is 15°C to 35°C, wherein the most preferred temperature range used for the reaction is 25°C to 30°C. The reaction is maintained under stirring for 4 to 6 hours. After the reaction, the solid product separated may be filtered and taken in water or the reaction is continued as such without filtration. Ammonia in the form of gaseous ammonia or aqueous ammonia is added to the reaction mass for amide formation. The reaction is carried out at a temperature in the range of 50-80°C. The time for the completion of the amidation reaction is 4-12 hours. The compound l-[(2,6-difluorophenyl)methyl]-lH-l,2,3-triazole-4-carboxamide (Rufinamide) of Formula I is isolated by filtration at 25-30°C and dried till constant weight.
In yet another embodiment of the present invention 2,6-difluorobenzyl bromide of Formula IIA, undergoes regioselective cycloaddition reaction with propargyl alcohol of Formula IXB, in presence of an azide, Cu(I) species, phase transfer catalyst, potassium iodide and solvent at a moderate temperature condition to get [l-(2,6-difluorobenzyl)-lH- l,2,3-triazol-4-yl]methanol of Formula XA.
The azide compound used in regioselective cycloaddition reaction is sodium azide. The Cu(I) species used for the reaction is generated insitu by reaction of Cu(II) species with reducing agent selected from sodium bisulfite, sodium metabisulfite, ascorbic acid or its salts preferably sodium ascorbate. The Cu(II) species used for the reaction are selected from CuS04.5H20, CuCl2, Cul2, Cu/A10(OH) or Cu(II) salts supported on carbon, silica or alumina. Alternatively Cu(I) species can be obtained directly from Cul, CuCl or any other cuprous salt. The preferred Cu(II) species used in the reaction is CuS04.5H20 with sodium ascorbate.
The catalyst used in the regioselective cycloaddition reaction is phase transfer catalyst selected from tetrabutyl ammonium bromide, tetrabutyl ammonium chloride, benzyl triethyl ammonium chloride and benzyl triethyl ammonium bromide. The preferred phase transfer catalyst used is tetrabutyl ammonium bromide.
The solvent used for the regioselective cycloaddition reaction is selected from polar solvents such as water, C C4 linear or branched alcohol, acetone, ethyl acetate, methyl ethyl ketone and methyl isobutyl ketone, acetonitrile, dimethylsulfoxide, N,N- dimethylformamide either single or mixture thereof. The preferred solvent used for the reaction is selected from water and C1-C4 linear or branched alcohol, wherein Ci-C4 linear or branched alcohol are selected from methanol, ethanol, w-propanol, n-butanol, isopropanol, and tert-butanol. The most preferred solvent used for the regioselective cycloaddition reaction is mixture of water and tert-butanol. The ratio of solvent mixture of water and tert-butanol used for the reaction is 1 : 15 or 15: 1 v/v, wherein the preferred ratio of water and tert-butanol is in the ratio of 1 : 9 v/v.
The regioselective cycloaddition reaction is carried out at moderate temperature in the range of 10°C to 50°C, wherein the preferred temperature for the reaction is 15°C to 35°C and the most preferred temperature used for the reaction is 25°C to 30°C.
Accordingly, the reaction temperature is maintained at 25°C to 30°C under stirring for 4 to 6 hours. After the completion of the reaction, ammonia in the form of gaseous ammonia or aqueous ammonia is added to the reaction mass and stirred for 2 to 4 hours at 0°C to 10°C. Filtered the solid compound of [l-(2,6-difluorobenzyl)-lH-l,2,3-triazol-4- yl]methanol of Formula XA. In another embodiment of the present invention, the compound [l-(2,6-difluorobenzyl)- lH-l,2,3-triazol-4-yl]methanol of Formula XA is subjected to oxidation reaction in presence of a buffer, a catalyst, an oxidizing agent and solvent to get the compound 1- (2,6-difluorobenzyl)-lH-l,2,3-triazole-4-carboxylic acid of Formula XB.
The buffer used for the oxidation reaction is selected from sodium dihydrogen phosphate, disodium hydrogen phosphate, and ammonium acetate, either single or mixture thereof. The preferred buffer used for the reaction is mixture of sodium dihydrogen phosphate and disodium hydrogen phosphate. The molar ratio of the mixture of sodium dihydrogen phosphate and disodium hydrogen phosphate used is 0.5: 1.0 to 1.0: 0.5. The preferred molar ratio of sodium dihydrogen phosphate and disodium hydrogen phosphate used is 1.0: 0.9.
The catalyst used for the oxidation reaction is (2,2,6,6-Tetramethylpiperidin-l-yl)oxyl [TEMPO]. The oxidizing agent used is mixture of sodium chlorite and sodium hypochlorite in the molar ratio of 2.5: 0.5.
The solvent used for the oxidation reaction is selected from acetonitrile, N,N- dimethylformamide, Ν,Ν-dimethylacetamide, dimethylsulfoxide and tetrahydrofuran. The preferred solvent used for the oxidation reaction is selected from acetonitrile and tetrahydrofuran, wherein the most preferred solvent used for the oxidation reaction is tetrahydrofuran.
The oxidation reaction is carried out at temperature in the range of 20°C to 40°C, wherein the preferred temperature of the oxidation reaction is between 35°C to 40°C. The time for completion of oxidation reaction is 4 to 6 hours. After completion of oxidation reaction the pH of the reaction mass is adjusted to 8 - 9 using aqueous sodium hydroxide solution. The reaction solution is extracted with toluene or diethyl ether and separated the organic layer. The pH of the aqueous layer is adjusted to 1 - 2 using dilute aqueous hydrochloric acid. The reaction mass is cooled to 0°C to 5°C and maintained 2 - 3 hours under stirring. Filtered the solid product of l-(2,6-difluorobenzyl)-lH-l,2,3-triazole-4-carboxylic acid of Formula XB. The compound l-(2,6-difluorobenzyl)-lH-l,2,3-triazole-4-carboxylic acid of Formula XB can be converted to rufinamide as per the process disclosed in the prior art process US pat. No.4789680
The reaction sequence of the present invention can be represented as in scheme 5;
Figure imgf000015_0001
Fopnula IIA Formula IXB Formula XA
Figure imgf000015_0002
Formula I
Formula XB
Scheme 5
In one of the embodiment, for the compound of Formula IX wherein R is -CN, the corresponding compound of Formula X can be hydrolysed, with aqueous sodium hydroxide at temperature of 90°C to 100°C to isolate the final compound Rufinamide of Formula I.
In yet another embodiment, the compound of Formula IX where R is -CH2OR2, wherein R2 is hydroxyl protecting group selected from acetyl, benzyl or benzoyl groups results in an intermediate triazole compound which is first deprotected by suitable deprotecting method to get the compound of Formula XA. This is followed by a process for the preparation of Rufinamide of Formula I as per the reaction scheme 5 described above.
In another embodiment, the present invention discloses the novel compound [l-(2,6- difluorobenzyl)-lH-l,2,3-triazol-4-yl]methanol, of Formula XA;
Figure imgf000016_0001
Formula XA
Thus the present invention demonstrates an improved, efficient process for the preparation of Rufinamide which is substantially free from the regio isomer impurities, with reduced number of steps and giving good yield.
The present invention is further illustrated in detail with reference to the following examples. It is desired that the example be considered in all respect as illustrative and are not intended to limit the scope of the claimed invention.
EXAMPLES:
Example 1: Preparation of [l-(2,6-difluorobenzyl)-lH-l,2,3-triazol-4-yl] methanol:
In a 100 ml 4 neck flask was charged 2, 6-difluorobenzyl bromide (lOg), sodium azide (6.26 gm), propargyl alcohol (5.4 g), copper sulfate pentahydrate (0.6g), sodium ascorbate( 1.9g), TBAB (1.54g), potassium iodide (0.8g) and a mixture of solvent tert- butanol and water (lOOml).The reaction mixture was stirred for 4 hrs at 25 - 30°C. On completion of the reaction, was charged aqueous ammonia (100 volumes) to the reaction mass and stirred for 2 hours at 25 - 30°C. Charged water (100 ml), stirred for 30 minutes and cooled to 5 - 10°C. Maintained at 5 - 10°C for 1 hour and filtered the product [l-(2,6- difluorobenzyl)-lH-l,2,3-triazol-4-yl]methanol, dried at 50-55°C till constant weight, m.p.: 1 17-121°C.
Ή-NMR (DMSO-de) 400 MHz: 5(ppm) 7.97 (s, 1H), 7.50 (m, 1H), 7.15 -7.22 (d, 2H),
5.63 (s, 2H), 5.19 (t, OH), 4.50 (d, 2H); 13C-NMR (DMSO-de): d (ppm) 40.70, 54.9,
1 1 1.50, 1 1 1.9, 1 12.0, 122.98, 131.7, 148.2, 159.6, 162.1.
IR (cm '): 3230.61, 1460, 1473.99, 1200, 1272, 1 150, 1 130.2, 1030.68
MS (M+l): 226.
Yield = 9.0 g;
HPLC purity = 99.50%. Example 2: Preparation of l-(2,6-difluorobenzyl)-lH-l,2,3-triazole-4-carboxylic acid:
To a 500 ml 4 neck RB flask was charged [l-(2,6-difluorobenzyl)-lH-l,2,3-triazol-4- yl]methanol (5.0g), tetrahydrofuran (50 ml) ,ΤΕΜΡΟ (0.23g), mixture of NaH2P04 and Na2HP04 buffer (125 ml). Stirred the reaction mass at 30 - 35°Cfor 15 minutes. Charged simultaneously 20 % of the mixture of aqueous solution of sodium chlorite (4.96 gm in 33 ml water) and sodium hypo chlorite (20 ml, in 20 ml of water). After completion of addition, maintained the reaction mass for 4 - 6 hours at temperature 35 - 40°C. After completion of the reaction adjusted pH of the reaction mass to 8 - 9 with aqueous 2N sodium hydroxide solution. Quenched the reaction mass in sodium sulfite solution (12 gm in 50 ml of water) and extracted with 50 ml of toluene, separated the organic layer. Adjusted pH of the reaction mass to 1 - 2 with 2N hydrochloric acid and cooled the reaction mass to 0 to 5°C. Maintained at 0 to 5°C for 2 hrs and filtered the compound 1- (2,6-difluorobenzyl)-lH-l,2,3-triazole-4-carboxylic acid and dried till constant weight. Yield = 5.0 g;
HPLC purity = 99.80%.
Example 3: Preparation of Rufinamide:
In a 100 ml flask was charged l-(2,6-difluorobenzyl)-lH-l,2,3-triazole-4-carboxylic acid (1.5 gm) and thionyl chloride (15 ml). Refluxed the reaction mass for 2.0 hours. Distilled out excess of thionyl chloride using toluene under vacuum. Diluted the reaction mass with toluene and quenched the solution slowly over 30 minutes in pre cooled aqueous ammonia (15 ml) maintaining temperature at 5 - 10°C. Stirred the reaction mass for 30 minutes and diluted the reaction mass with ethanol (30 ml). Filtered the solid l-[(2,6- difluorophenyl)methyl]- 1 Η- 1 ,2,3-triazole-4-carboxamide [Rufinamide] .
Yield = 1.3 g;
HPLC purity = 99.40%.
Regio Isomer = Not detected
Example 4: Preparation of Rufinamide:
In a 50ml R.B flask, 2,6-Difluorobenzyl bromide (l .Og), sodium azide (0.344g), propiolamide (0.33g), copper sulfate pentahydrate (0.12g), sodium ascorbate (0.191g), a mixture of water and tert-butanol (1 :1,15ml) were added. The reaction mixture was stirred at R.T (25 °C) for 15 hours. On completion of reaction, the reaction mass was filtered, washed with water and dried under vacuum till constant weight to get
Rufinamide.
Yield = 0.9 g;
HPLC purity =99.53%.
Regio Isomer = Not detected
Example 5: Preparation of Rufinamide:
In a 50ml R.B flask, 2,6-Difluorobenzyl bromide (lg), sodium azide (0.344g), methylpropiolate (0.406g), copper sulfate pentahydrate (0.12g), sodium ascorbate (0.191g), a mixture of water and ter/-butanol (1 :1,15ml) were added. The reaction mixture was stirred at 25-30°C for 20 hours. On completion of reaction 30 ml water was added and the solid product was filtered. The solid was suspended in 7.5 ml water and to this 7.5 ml aqueous ammonia solution (25%) was added. The reaction mixture was stirred at 60-70°C for 4 hours. On completion of reaction (TLC), the reaction mass was cooled to 25-30°C, filtered , washed with water and dried under vacuum till constant weight to get Rufinamide.
Yield = 0.82 g;
HPLC purity = 99.57%.
Regio Isomer = Not detected
Example 6: Preparation of Rufinamide
In a 2.5 litre R.B flask was charged 2,6-difluorobenzyl bromide (lOOg), sodium azide (34.4g), propiolamide (33g), copper sulfate pentahydrate (12g), sodium ascorbate (19.1g,), TBAB (15.55 g), KI (8.02g) in the mixture of water and tert-butanol (1:1, 1.5 It). The reaction mixture was stirred at 25 °C - 30°C for 15 hours. On completion of reaction (TLC), the reaction mass was filtered, washed with water and dried under vacuum till constant weight to yield Rufinamide.
Yield: 90.0 g
HPLC purity: 99.53%
Regioisomer: Not detected Example7: Preparation of Rufinamide
In a 5.0 litre R.B flask, was charged 2,6-difluorobenzyl bromide (lOOg), sodium azide (34.4g), methylpropiolate (40.6g), copper sulfate pentahydrate (12g), sodium ascorbate (19.1g), TBAB (15.55 g), KI (8.02g) in the mixture of water and r/-butanol (1:1,1.5 It). The reaction mixture was stirred at 25°C - 30°C for 20 hours. On completion of reaction, charged 1.0 It DM water and the solid product was filtered. The solid was suspended in 750 ml water and to this 750 ml aqueous ammonia solution (25%) was added. The reaction mixture was stirred at 60-70°C for 4 hours. On completion of reaction (TLC), the reaction mass was cooled, filtered, washed with water and dried the compound Rufinamide under vacuum till constant weight.
Yield: 82.0 g
HPLC purity: 99.55%
Regioisomer: Not detected

Claims

We Claim,
1. A process for the preparation of Rufinamide of Formula I,
Figure imgf000020_0001
Formula I
comprising;
regioselective cycloaddition of 2,6-difluorobenzyl halide of Formula II,
Figure imgf000020_0002
Formula II
wherein X is chloride, bromide or iodide;
with a compound of Formula IX;
Figure imgf000020_0003
Formula IX
where R is -COORi, wherein Ri is hydrogen, C1-C4 linear or branched alkyl group, or -CN, or -CONH2 or
Figure imgf000020_0004
where R2 is hydrogen or hydroxyl protecting group; in presence of an azide, Cu(I) species and a catalyst.
2. The process as claimed in claim 1 ; wherein the azide is selected from metal azide or alkyl silyl azide.
3. The process as claimed in claim 2; wherein the metal azide is sodium azide or potassium azide and alkyl silyl azide is trimethylsilyl azide.
4. The process as claimed in claim 1 ; wherein the Cu(I) species is generated insitu by reaction of Cu(II) species with a reducing agent.
5. The process as claimed in claim 4; wherein the Cu(II) species is selected from CuS04.5H20, CuCl2, Cul2, Cu/A10(OH) or Cu(II) salts supported on carbon, silica and alumina.
6. The process as claimed in claim 4; wherein the reducing agent is selected from sodium bisulfite, sodium metabisulfite, ascorbic acid or its salts thereof.
7. The process as claimed in claim 1 ; wherein the catalyst for the reaction is phase transfer catalyst selected from tetrabutyl ammonium bromide, tetrabutyl ammonium chloride, benzyl triethyl ammonium chloride and benzyl triethyl ammonium bromide.
8. The process as claimed in claim 1; wherein the regioselective cycloaddition reaction is carried out in presence of polar solvent.
9. The process as claimed in claim 8; wherein the polar solvent is selected from water, Q-C4 linear or branched alcohol, acetone, ethyl acetate, methyl ethyl ketone, methyl isobutyl ketone, acetonitrile, dimethylsulfoxide, N,N- dimethylformamide or mixture thereof.
10. The process as claimed in claim 1 ; wherein the regioselective cycloaddition reaction is carried out in presence of potassium iodide.
11. The process for the preparation of Rufinamide as claimed in claim 1, comprises the steps of;
a. regioselective cycloaddition of 2,6-difluorobenzyl halide of Formula II,
Figure imgf000021_0001
Formula II
wherein X is chloride, bromide or iodide;
with propargyl alcohol of Formula IXB;
Figure imgf000021_0002
Formula IXB
in presence of an azide, Cu(I) species, catalyst and solvent to obtain the compound [l-(2,6-difluorobenzyl)-lH-l,2,3-triazol-4-yl]methanol of Formula XA;
Figure imgf000021_0003
Formula XA Oxidation of the compound of Formula XA with an oxidizing agent in presence of a buffer, a catalyst, and solvent to obtain the compound l-(2,6- difluorobenzyl)-lH-l,2,3-triazole-4-carboxylic acid of Formula XB; and
Figure imgf000022_0001
Formula XB
c. Converting the compound of Formula XB to Rufinamide of Formula I.
12. The process as claimed in claim 11(a); wherein the azide is selected from sodium azide, potassium azide and trimethylsilyl azide.
13. The process as claimed in claim 11(a); wherein the Cu(I) species is generated insitu by reaction of Cu(II) species with a reducing agent.
14. The process as claimed in claim 13; wherein the Cu(II) species for the reaction is selected from CuS04.5H20, CuCl2, Cul2, Cu/A10(OH) or Cu(II) salts supported on carbon, silica and alumina.
15. The process as claimed in claim 13; wherein the reducing agent is selected from sodium bisulfite, sodium metabisulfite, ascorbic acid or its salts thereof.
16. The process as claimed in claim 11(a); wherein the catalyst for the reaction is phase transfer catalyst selected from tetrabutyl ammonium bromide, tetrabutyl ammonium chloride, benzyl triethyl ammonium chloride and benzyl triethyl ammonium bromide.
17. The process as claimed in claim 11(a); wherein the polar solvent is selected from water, C1-C4 linear or branched alcohol, acetone, ethyl acetate, methyl ethyl ketone, methyl isobutyl ketone, acetonitrile, dimethylsulfoxide, N,N- dimethylformamide or mixture thereof.
18. The process as claimed in claim 11(a); wherein the regioselective cycloaddition reaction is carried out in presence of potassium iodide.
19. The process as claimed in claim 11(b); wherein the oxidizing agent is a mixture of sodium chlorite and sodium hypochlorite.
20. The process as claimed in claim 11(b); wherein the buffer is selected from sodium dihydrogen phosphate, disodium hydrogen phosphate, and ammonium acetate, either single or mixture thereof.
21. The process as claimed in claim 20; wherein the buffer is selected from a mixture of sodium dihydrogen phosphate and disodium hydrogen phosphate.
22. The process as claimed in claim 21 ; wherein the molar ratio of the mixture of sodium dihydrogen phosphate and disodium hydrogen phosphate is 0.5: 1.0 to 1.0:
0.5.
23. The process as claimed in claim 1 1 (b); wherein the solvent for the oxidation reaction is selected from acetonitrile, Ν,Ν-dimethylformamide, N,N- dimethylacetamide, dimethylsulfoxide and tetrahydrofuran.
24. The process as claimed in claim 23; wherein the solvent for the oxidation reaction is acetonitrile and tetrahydrofuran.
25. The process as claimed in claim 1 1(b); wherein the catalyst for the oxidation reaction is (2,2,6,6-Tetramethylpiperidin-l-yl)oxyl.
26. The compound [l-(2,6-difluorobenzyl)-lH-l,2,3-triazol-4-yl]methanol of Formula XA;
Figure imgf000023_0001
Formula XA
PCT/IN2011/000607 2010-09-06 2011-09-05 Process for preparation of fluorinated triazole compound WO2012032540A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2477MU2010 2010-09-06
IN2477/MUM/2010 2010-09-06

Publications (1)

Publication Number Publication Date
WO2012032540A1 true WO2012032540A1 (en) 2012-03-15

Family

ID=45464035

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2011/000607 WO2012032540A1 (en) 2010-09-06 2011-09-05 Process for preparation of fluorinated triazole compound

Country Status (1)

Country Link
WO (1) WO2012032540A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013105029A1 (en) * 2012-01-10 2013-07-18 Lupin Limited Process for preparation of rufinamide
WO2014120994A1 (en) * 2013-01-31 2014-08-07 The Johns Hopkins University Rufinamide and derivatives and their use in modulating the gating process of human voltage-gated sodium channels
WO2014121383A1 (en) * 2013-02-11 2014-08-14 Apotex Technologies Inc. A process for the preparation of rufinamide and intermediates thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789680A (en) 1982-12-23 1988-12-06 Ciba-Geigy Corporation Aralkyltriazole compounds
WO1998002423A1 (en) 1996-07-11 1998-01-22 Novartis Ag Process for preparing 1-substituted 4-cyano-1,2,3-triazoles
WO2010043849A1 (en) 2008-10-13 2010-04-22 Cipla Limited Process for the preparation of rufinamide
EP2230234A1 (en) * 2009-03-16 2010-09-22 Dipharma Francis S.r.l. Process for the preparation of rufinamide
WO2011135105A1 (en) * 2010-04-30 2011-11-03 Laboratorios Lesvi, S.L. Improved process for preparing rufinamide intermediate

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789680A (en) 1982-12-23 1988-12-06 Ciba-Geigy Corporation Aralkyltriazole compounds
WO1998002423A1 (en) 1996-07-11 1998-01-22 Novartis Ag Process for preparing 1-substituted 4-cyano-1,2,3-triazoles
WO2010043849A1 (en) 2008-10-13 2010-04-22 Cipla Limited Process for the preparation of rufinamide
EP2230234A1 (en) * 2009-03-16 2010-09-22 Dipharma Francis S.r.l. Process for the preparation of rufinamide
WO2011135105A1 (en) * 2010-04-30 2011-11-03 Laboratorios Lesvi, S.L. Improved process for preparing rufinamide intermediate

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
ROSTOVTSEV V V ET AL: "A Stepwise Huisgen Cycloaddition Process: Copper(I)-Catalyzed Regioselective Ligation of Azides and Terminal Alkynes", ANGEWANDTE CHEMIE. INTERNATIONAL EDITION, WILEY VCH VERLAG, WEINHEIM, vol. 41, no. 14, 1 January 2002 (2002-01-01), pages 2596 - 2599, XP002524189, ISSN: 1433-7851, DOI: 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4 *
WANG JUNMIN ET AL: "Synthesis and anticonvulsant activity of 1-substituted benzyl N-substituted 1,2,3-triazole-4-carboxanilides", PROGRESS IN NATURAL SCIENCE, SCIENCE PRESS, BEIJING, CN, vol. 16, no. 9, 1 September 2006 (2006-09-01), pages 925 - 929, XP009124641, ISSN: 1002-0071, DOI: 10.1080/10020070612330090 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013105029A1 (en) * 2012-01-10 2013-07-18 Lupin Limited Process for preparation of rufinamide
WO2014120994A1 (en) * 2013-01-31 2014-08-07 The Johns Hopkins University Rufinamide and derivatives and their use in modulating the gating process of human voltage-gated sodium channels
WO2014121383A1 (en) * 2013-02-11 2014-08-14 Apotex Technologies Inc. A process for the preparation of rufinamide and intermediates thereof

Similar Documents

Publication Publication Date Title
US8183269B2 (en) Process for the preparation of rufinamide
US8871945B2 (en) Process for preparation of rufinamide
EP2230234B1 (en) Process for the preparation of rufinamide
AU2013293974B2 (en) Method for Producing 4-[5-(Pyridin-4-yl)-1H-1,2,4-Triazol-3-yl]Pyridin-2-Carbonitrile, and Intermediate thereof
WO2007144896A1 (en) A method of manufacture of letrozole
WO2012032540A1 (en) Process for preparation of fluorinated triazole compound
JP3378315B2 (en) Carbazolone derivative and method for preparing the same
EP2563766A1 (en) Improved process for preparing rufinamide intermediate
US8003804B2 (en) Synthesis of 4-[1-(4-cyano phenyl)-(1,2,4-triazol-1-yl)methyl] benzonitrile and 4-[1-(1H-1,2,4-triazol-1-yl)methylene benzonitrile intermediate
US20090286989A1 (en) Process for High Purity Anastrozole
WO2007039912A1 (en) A one pot process for the preparation of 4-[1-cyanophenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile
US8288561B2 (en) Process for preparing valsartan
US8198460B2 (en) Process for preparation of letrozole and its intermediates
US20160304458A1 (en) Synthesis of an azasugar and the intermediates thereof
CN110078677A (en) A kind of preparation method of metconazole
WO2022191139A1 (en) Method for producing 3-bromo-1-(3-chloropyridin-2-yl)-1h-pyrazole-5-carboxylic acid ester
WO2013105029A1 (en) Process for preparation of rufinamide
Yang et al. The reaction of heteroaroyl‐substituted heterocyclic ketene aminals with 2, 3, 4, 6‐tetra‐O‐acetyl‐β‐d‐glucopyranosyl azide
CA2431821C (en) Method for the production of 2-(2-ethoxyphenyl)-substituted imidazotriazinones
US9212152B2 (en) Process for the preparation of N-hydroxy-1-(1-alkyl-1H-tetrazol-5-yl)-1-phenylmethanimine derivatives
RU2186771C2 (en) Method of synthesis of compounds of 5-(alkoxy-methyl)-2,3-pyridine carboxamide, intermediate compounds
WO2021162070A1 (en) Method for producing monomer for nucleic acid production
JP2004238322A (en) Method for producing (r)-3-aminopentanenitrile methanesulfonic acid salt
RU2167870C2 (en) Selective chlorination of 1-(2-fluorophenyl)-4,5-dihydro-3-methyl-5-oxo-1h-1,2,4-triazole
JPH06298684A (en) Production of new 4-(2-substituted)-phenylbenzyl bromide

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11805620

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11805620

Country of ref document: EP

Kind code of ref document: A1